Clinical Trial Update: GSK2190915 Moderate to Severe Asthma Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GSK2190915 in moderate to severe asthma; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2018-03-01